23948sdkhjf
Log in or create to bookmark articles
Get access to all content on Life Science Nordic
No commitment or card information required
Applies to personal subscription only.
Contact us for a enterprise solution.
Advertisement
Advertisement

Bavarian Nordic names Tarja Stenvall new CEO

Danish vaccine maker Bavarian Nordic has appointed Tarja Stenvall as its new President and CEO, succeeding Paul Chaplin.
Advertisement

Tarja Stenvall has more than 20 years of experience in the pharmaceutical industry, having held senior positions at Sanofi, AstraZeneca and Pfizer.

Most recently, she served as Senior Vice President and Head of Global Franchise for diabetes and cardiovascular diseases at Sanofi. She has also held senior roles within Sanofi’s vaccines business, including as Vice President for Vaccines in Latin America.

Advertisement Advertisement
BREAKING
{{ article.headline }}
0.063|instance-web02